Physician profile
Sei Chung
NPI 1972038255
$3,396.53
in general payments reported to CMS, 2019-2025
7 companies · $2,117 in 2025
The $2,117 reported for 2025 was more than what 90% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,280 · 2025: $2,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,178 · Travel and Lodging: $1,158 · Consulting Fee: $1,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,178.19 |
| Travel and Lodging | $1,158.34 |
| Consulting Fee | $1,060.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,560.22 | 2025 | Dupixent |
| Genzyme Corporation | $1,312.68 | 2024-2025 | |
| Glaxosmithkline, LLC. | $285.15 | 2024-2025 | Nucala |
| Medtronic, INC. | $139.04 | 2024-2025 | Stealthstation S8 Platform, Fusion |
| Integra Lifesciences Corporation | $83.33 | 2025 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
| Aerin Medical INC. | $16.11 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sei Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.